The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAAA.L Regulatory News (AAA)

  • There is currently no data for AAA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Extension of reporting deadline & portfolio update

26 Jun 2020 13:22

RNS Number : 2584R
All Active Asset Capital Limited
26 June 2020
 

26 June 2020

 

All Active Asset Capital Limited

('AAAC' or 'the Company')

Extension of reporting deadline for publication of the annual report and financial statements for the year ended 31 December 2019 ('Annual Report')

Portfolio update

Change of broker

Extension of financial reporting deadline and update on investment in Myanmar Allure Group Co., Ltd

AAAC has a 7% equity investment in Myanmar Allure Group Co., Ltd. ("the Myanmar Investment"), a company that owns and operates a combined hotel, resort and gaming facility in Myanmar. The COVID-19 lockdown has prevented the Company from obtaining up to date information about the trading performance and financial situation of the Myanmar Investment, which was the sole investment held by AAAC as at 31 December 2019. The Company has been informed that the facility has been closed, due to the COVID-19 situation.

 

The Myanmar Investment (reflected in the Company's balance sheet as at 31 December 2018 at a valuation of £971,252) is a substantial component of the Company's gross assets in the Company's Annual Report and, as an investment in an unlisted equity security, the Myanmar Investment requires an annual assessment of its fair value ("the Valuation Report") as part of the Company's audit process.

 

Due to the COVID-19 pandemic and lockdown measures in Myanmar, preparation of the Valuation Report has been delayed. Given the material nature of the Myanmar Investment, the Valuation Report is fundamental to an audit opinion within the Annual Report.

 

The Company has applied to AIM Regulation, pursuant to the guidance provided by AIM Regulation in "Inside AIM" on 26 March 2020, for an additional period of up to three months to publish the Annual Report. AIM Regulation has granted the extension and therefore the Company will publish the Annual Report by no later than 30 September 2020. If it is possible to publish the Annual Report before this date, then the Board will seek to do so as promptly as possible.

 

The Company has consulted with its British Virgin Islands ("BVI") lawyers and has been advised that it is not necessary for the Company to file audited financial statements with the Registry of Corporate Affairs in the BVI. Accordingly, a delay in the publication of the Annual Report will not breach any regulations in the BVI.

Portfolio update

The Company did not make any new investments during the year ended 31 December 2019. In 2020, the Company made several investments relating to Asimilar Group plc ("Asimilar").

The Company's current investment portfolio comprises three assets: (i) the Myanmar Investment, as described above; (ii) equity, warrants and options over warrants in Asimilar; and (iii) cash reserves amounting to approximately £1.1 million following completion of the recent placing.

Asimilar is an AIM quoted technology-focused investing company. In the first half of 2020 the Company has acquired and holds the following interests in Asimilar:

- 1,200,000 Asimilar shares (representing 1.14% of Asimilar's current issued share capital), the details of which were announced by AAAC on 30 March 2020.

 

- an option to acquire warrants over 15,500,000 Asimilar shares, exercisable at 6p per Asimilar share each, expiring on 31 October 2020, the details of which were announced by AAAC on 14 May 2020.

 

- an option to acquire warrants over 5,000,000 Asimilar shares, exercisable at 18p per Asimilar share each, expiring on 30 September 2020, the details of which were announced by AAAC on 14 May 2020.

 

- an option to acquire warrants over 1,200,000 Asimilar shares, exercisable at 5p per Asimilar share each, expiring on 31 May 2022, the details of which were announced by AAAC on 20 March 2020.

 

- warrants over 240,000 Asimilar shares, exercisable at 5p per Asimilar share each, expiring on 31 May 2022, the details of which were announced by AAAC on 20 March 2020.

 

These investments in equity, warrants and options over warrants in Asimilar have an unaudited current carrying value of approximately £1.1 million, being their acquisition price.

Asimilar's shares were suspended from trading on AIM on 14 February 2020, due to Asimilar seeking to make a potential investment in Sentiance NV ("Sentiance"), which would comprise a 9.3% new equity stake, with options, which would increase Asimilar's holding to up to 35.9% of Sentiance's enlarged issued share capital. Sentiance is a private Belgian company, developing artificial intelligence software, machine learning and contextual behavioural data science.

Asimilar's potential Sentiance investment was classified as a reverse takeover under the AIM Rules; Asimilar's shares were trading at 47.5 pence when suspended. On 12 March 2020, Asimilar announced a placing to raise £7.5m at 60 pence per share, conditional on a number of matters, including Asimilar's enlarged share capital being admitted to trading on AIM. There can be no guarantee that Asimilar's potential Sentiance investment, nor the Asimilar placing will be completed, or of the final terms and timing of these transactions.

Change of Broker 

Allenby Capital Limited is now the Company's sole broker and remains the Company's nominated adviser.

 

For further information:

 

All Active Asset Capital Limited

James Normand, Non-Executive Chairman

Rodger Sargent, Executive Director

T: +44 (0) 7779 799431

www.aaacap.com

 

Allenby Capital Limited (Nominated Adviser and Broker)

Nick Athanas / Alex Brearley

T: +44 (0) 203 328 5656

www.allenbycapital.com

 

Buchanan (Financial PR)

Richard Oldworth / Chris Lane / Toto Berger

T: +44 (0) 207 466 5000

E: AAAC@buchanan.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFFMTTMTTTBMM
Date   Source Headline
25th Apr 20147:00 amRNSFinal Results
10th Dec 20139:26 amRNSResult of AGM
2nd Dec 20137:00 amRNSAppointment of Adviser
28th Nov 20137:00 amRNSFurther Investment in Myanmar
11th Nov 20138:43 amRNSNotice of AGM and Change of Investing Policy
8th Oct 20137:00 amRNSInvestment in Power Plant Development in Myanmar
20th Sep 20137:00 amRNSHalf Yearly Report
2nd Sep 20139:21 amRNSSigning of Letter of Intent
6th Jun 20134:40 pmRNSSecond Price Monitoring Extn
6th Jun 20134:35 pmRNSPrice Monitoring Extension
31st May 201310:45 amRNSChange of Registered Office
2nd May 20138:07 amRNSFirst day of dealings on AIM
2nd Aug 200611:29 amRNSIssue of Equity
13th Jul 20065:03 pmRNSShareholders Meeting
14th Jun 20067:01 amRNSInterim Results
8th May 200610:39 amRNSBoard Changes
3rd May 200611:24 amRNSIssue of Shares
2nd May 20067:02 amRNSAdastra Acquired
28th Apr 20067:03 amRNSConfirmation Adastra Approach
28th Apr 20067:02 amRNSRe. Proposal from Mwana
26th Apr 20062:21 pmRNSIncident in Kolwezi
25th Apr 20064:59 pmRNSIssue of Equity
21st Apr 20064:07 pmRNSIssue of Equity
19th Apr 20063:14 pmRNSExtension For Adastra
19th Apr 20067:01 amRNSImproved Offer Mailout
18th Apr 20064:26 pmRNSHolding(s) in Company
3rd Apr 20067:03 amRNSAdastra Offer Extended
31st Mar 20067:00 amRNSOffer Update
29th Mar 20065:19 pmRNSSite Works to Commence
28th Mar 20067:00 amRNSOffer Update
24th Mar 20068:55 amRNSSubsurface Sampling Results
24th Mar 20068:12 amRNSRejects FQ's Final Offer
21st Mar 20067:02 amRNSResponse to FQM Final Offer
20th Mar 20062:30 pmRNSIncrease In Offer For Adastra
17th Mar 20067:02 amRNS1st Quarter Results
15th Mar 20068:08 amRNSre Shareholder Rights Plan
10th Mar 20061:17 pmRNSAGM Statement
10th Mar 20068:01 amRNSOffer for Adastra extended
8th Mar 20061:13 pmRNSCompletion of DFS and ESIA
8th Mar 20067:03 amRNSIssue of Equity
27th Feb 20069:20 amRNSResponse to FQM
24th Feb 20067:01 amRNSOffer To Acquire Adastra
8th Feb 200610:34 amRNSIndaba Presentation
7th Feb 20061:20 pmRNSHolding(s) in Company
7th Feb 20067:01 amRNSIDC and Investec Mandates
3rd Feb 20062:41 pmRNSComment on Formal Bid
2nd Feb 20068:01 amRNSFormal Bid For Adastra
31st Jan 20067:01 amRNSFinal Results
25th Jan 20067:01 amRNSIssue of Equity
24th Jan 20067:01 amRNSFirst Quantum Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.